Form 4 for EHC Encompass Health Corp
Accepted 2023-02-24 00:00:00 ET · period of report 2023-02-23 · accession 0001127602-23-006965 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-02-24 | 2023-02-23 | EHC | Price Andrew L | CAO | A - Grant | $0.00 | +7,114 | 73.2K | +11% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Encompass Health Common Stock | 2023-02-23 | A | A | 4,388 | $0.00 | 70,450 | D | — | — | (F1) This issuance of restricted stock is the result of the satisfaction of certain performance criteria set out in the terms of a performance share unit award made on February 24, 2021. |
| 2 | Common | Encompass Health Common Stock | 2023-02-23 | A | A | 2,726 | $0.00 | 73,176 | D | — | — | (F2) Annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan. |